Landscape and Construction of a Novel N6-methyladenosine-related LncRNAs in Cervical Cancer

被引:0
|
作者
Xin Liu
Weijie Zhang
Jun Wan
Diming Xiao
Ming Wei
机构
[1] The Fifth Affiliated Hospital of Zhengzhou University,Department of Blood Transfusion Department
[2] The Fifth Affiliated Hospital of Zhengzhou University,Department of Pharmacy Department
[3] The Fifth Affiliated Hospital of Zhengzhou University,Department of General Practice Department
来源
Reproductive Sciences | 2023年 / 30卷
关键词
Cervical cancer; lncRNA; Prognosis; N6-methyladenosine; The Cancer Genome Atlas;
D O I
暂无
中图分类号
学科分类号
摘要
Cervical cancer is a crucial clinical problem with high mortality. Despite much research in therapy, the prognosis of patients with cervical cancer is still not ideal. The data on cervical cancer were downloaded from The Cancer Genome Atlas (TCGA) portal. R language was used to screen out the N6-methyladenosine (m6A)-related lncRNAs (long non-coding RNA). A consensus clustering algorithm was performed to identify m6A-related lncRNAs in cervical cancer; 10 m6A-related lncRNAs showing a significant association with survival were filtrated through a gradually univariate Cox regression model, least absolute shrinkage and selection operator (LASSO) algorithm, and multivariate Cox regression preliminarily. Furthermore, we conducted Kaplan-Meier curves, receiver operating curve (ROC) analyses, and proportional hazards model to quantify the underlying character of the m6A-related model in the prevision of cervical cancer patients. Gene set enrichment analysis (GSEA) was used to explore several pathways significantly. Finally, cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was applied to estimate the immune cell infiltration in the profiling. In the present study, 10 m6A-related lncRNAs make up our prediction model. This prediction model can do duty for an independent predictive biomolecular element. Subsequently, we then found that the model was still valid in further validation of the training group and the test group. Our signature was correlated with immune cell infiltration and partial signaling pathway. These lncRNAs played a no negligible biomolecular role in contributing to the prognosis of cervical cancer.
引用
收藏
页码:903 / 913
页数:10
相关论文
共 50 条
  • [41] Comprehensive Analysis of N6-Methyladenosine-Related lncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma
    Chen, Xinyi
    Wang, Lu
    Tu, Jingyao
    Pan, Xin
    Li, Yuehan
    Yin, Han
    Wang, Moran
    Yuan, Xianglin
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2022, 32 (01): : 79 - 98
  • [42] Deciphering N6-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
    Zhu, Jie
    Wang, Min
    Hu, Daixing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [43] Comprehensive analyses of N6-methyladenosine-related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
    Luo, Yuejun
    Zhang, Zhihui
    Zheng, Bo
    Wu, Peng
    Zhang, Guochao
    Wang, Lide
    Zeng, Qingpeng
    Yang, Zhaoyang
    Xue, Liyan
    Zeng, Hua
    Tan, Fengwei
    Xue, Qi
    Gao, Shugeng
    Sun, Nan
    He, Jie
    CANCER SCIENCE, 2022, 113 (12) : 4289 - 4299
  • [44] N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
    Lu, Miaolong
    Zhan, Hailun
    Liu, Bolong
    Li, Dongyang
    Li, Wenbiao
    Chen, Xuelian
    Zhou, Xiangfu
    EPMA JOURNAL, 2021, 12 (04): : 589 - 604
  • [45] N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
    Miaolong Lu
    Hailun Zhan
    Bolong Liu
    Dongyang Li
    Wenbiao Li
    Xuelian Chen
    Xiangfu Zhou
    EPMA Journal, 2021, 12 : 589 - 604
  • [46] The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy
    Zou, Renrui
    Liu, Yaqian
    Qiu, Sangsang
    Lu, Ya
    Chen, Yan
    Yu, Hui
    Zhu, Hangju
    Zhu, Wenbo
    Zhu, Longbiao
    Feng, Jifeng
    Han, Jing
    CANCER BIOMARKERS, 2023, 38 (04) : 551 - 566
  • [47] ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability
    Tian, Jianbo
    Ying, Pingting
    Ke, Juntao
    Zhu, Ying
    Yang, Yang
    Gong, Yajie
    Zou, Danyi
    Peng, Xiating
    Yang, Nan
    Wang, Xiaoyang
    Mei, Shufang
    Zhang, Yuxing
    Wang, Changyi
    Zhong, Rong
    Chang, Jiang
    Miao, Xiaoping
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (12) : 3281 - 3293
  • [48] Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
    Zhang, Li
    Tang, Xianzhe
    Wan, Jia
    Zhang, Xianghong
    Zheng, Tao
    Lin, Zhengjun
    Liu, Tang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [49] An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma
    Zhang, Huijuan
    Hu, Jing
    Liu, Aina
    Qu, Huajun
    Jiang, Fenge
    Wang, Congcong
    Mo, Steven
    Sun, Ping
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [50] Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
    Zhang, Lemeng
    Luo, Yongzhong
    Cheng, Tianli
    Chen, Jianhua
    Yang, Hua
    Wen, Xiaoping
    Jiang, Zhou
    Li, Haitao
    Pan, Changqie
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 1549 - 1563